Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- JPMA to Suspend Hasegawa’s Veep Activities for Another 6 Months over CASE-J
September 19, 2014
- CDISC CEO Advises Drug Makers to Collect Data Based on CDASH
August 27, 2014
- NEDO, NCC, Toray to Jointly Develop Simple Test Systems for Cancers and Dementia
August 20, 2014
- Fair Discussions Necessary for Full Introduction of New Drug Development Premium: Chuikyo Member
August 12, 2014
- Drug Price Settlement Rate Will Rise towards Sept.: JPWA Chief
August 11, 2014
- OTC Drug Federation Requests Ministry to Advance Prescription-to-OTC Switches
July 31, 2014
- Generic Drugs See 45.1% Market Share in FY2013 in New Calculation
July 29, 2014
- JPMA President Hints at Adoption of Unified System to Disclose Fees Paid to Doctors Next Year
July 25, 2014
- Kampo Manufacturers Group Names Tsumura President as New Chairman
July 24, 2014
- Number of Drug Reps Rebounds to 65,752 in FY2013, Buoyed by Major Product Debuts
July 23, 2014
- Medwatcher Elbows Expert Group to Disclose Financial Links with HPV Vaccine Makers
July 22, 2014
- Generic Switch Saved 22.7 Billion Yen in Drug Costs over 5 Years: Kyokai Kenpo
July 17, 2014
- JGA to Use Independent Organizations to Conduct GMP Inspections of Overseas Drug Substance Production Facilities
July 17, 2014
- Cochrane Collaboration Establishes Japanese Branch; Co-Director Calls for “Full Disclosure” of Clinical Research
July 14, 2014
- Medwatcher Wants Structural Problems of Pharma Industry and Researchers Revealed During Diovan Trials
July 3, 2014
- JMA Exec Matsumoto Tipped to Replace Adachi as Chuikyo Rep
July 3, 2014
- “No Need to Step Down” as Chair of Biz Lobby, Govt Panel Member: Takeda CEO
July 2, 2014
- Yokokura Reelected as JMA President, 3 Incumbents Retain Veep Seats
July 2, 2014
- Research-Driven Pharmas Could Diverge into 2 Groups Based on Dependence on Off-Patent Drugs: FPMAJ Chair
July 1, 2014
- Min-Iren Urges Novartis to Return “Unfair Profits”
June 24, 2014
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…